REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system ...

Gene editing sounds like progress until it becomes policy. This story follows a future where CRISPR and AI reshape humanity ...

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing ...

Market OverviewThe global cell and gene therapy market is undergoing rapid and transformative growth, reflecting its increasing importance in modern healthcare.The market is projected to expand at a ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

Google DeepMind announced it was making AlphaGenome’s source code and weights available to the science community for ...

Hologen, an AI biotech co-founded by former Google CEO Eric Schmidt, is seeking to raise $150 million in a Series A round at ...

Sidewinder achieves highly accurate assembly of long DNA sequences from scratch, offering a new leap forward for programmable biology ...

Explore brewing possibilities using caffeine to edit gene expression and discover how gene control technology could redefine precision medicine—learn more today.

"Aging has a relatively simple explanation and is apparently reversible." The post Scientists Testing Controversial Human ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic ...